205 related articles for article (PubMed ID: 3927867)
21. Outcomes of hospitalized neutropenic oncology patients with Pseudomonas aeruginosa bloodstream infections: focus on oral fluoroquinolone conversion.
Yan LZ; Herrington JD
J Oncol Pharm Pract; 2016 Aug; 22(4):584-90. PubMed ID: 26156260
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with improved outcome of Pseudomonas aeruginosa bacteremia in a Finnish university hospital.
Kuikka A; Valtonen VV
Eur J Clin Microbiol Infect Dis; 1998 Oct; 17(10):701-8. PubMed ID: 9865983
[TBL] [Abstract][Full Text] [Related]
23. Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes, with particular emphasis on the effect of antibiotic therapy.
Siegman-Igra Y; Ravona R; Primerman H; Giladi M
Int J Infect Dis; 1998; 2(4):211-5. PubMed ID: 9763504
[TBL] [Abstract][Full Text] [Related]
24. Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
Lee CH; Su TY; Ye JJ; Hsu PC; Kuo AJ; Chia JH; Lee MH
J Microbiol Immunol Infect; 2017 Oct; 50(5):677-683. PubMed ID: 26188977
[TBL] [Abstract][Full Text] [Related]
25. Bacteremia due to Pseudomonas aeruginosa complicating neoplastic disease: a progress report.
Tapper ML; Armstrong D
J Infect Dis; 1974 Nov; 130 Suppl(0):S14-23. PubMed ID: 4213872
[No Abstract] [Full Text] [Related]
26. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients.
Hilf M; Yu VL; Sharp J; Zuravleff JJ; Korvick JA; Muder RR
Am J Med; 1989 Nov; 87(5):540-6. PubMed ID: 2816969
[TBL] [Abstract][Full Text] [Related]
27. Combinations of antibiotics against Pseudomonas aeruginosa.
Baltch AL; Smith RP
Am J Med; 1985 Jul; 79(1A):8-16. PubMed ID: 3927722
[TBL] [Abstract][Full Text] [Related]
28. Pseudomonas aeruginosa bacteremia: resistance to antibiotics, risk factors, and patient mortality.
Vitkauskienė A; Skrodenienė E; Dambrauskienė A; Macas A; Sakalauskas R
Medicina (Kaunas); 2010; 46(7):490-5. PubMed ID: 20966623
[TBL] [Abstract][Full Text] [Related]
29. [Clinical analysis of Pseudomonas aeruginosa bacteremia].
Kumasaka K; Hosokawa N; Yanai M; Yagoshi M; Simoguchi K; Kawano K
Rinsho Byori; 1999 Nov; 47(11):1064-9. PubMed ID: 10590685
[TBL] [Abstract][Full Text] [Related]
30. Pseudomonas aeruginosa bacteremia in children: analysis of trends in prevalence, antibiotic resistance and prognostic factors.
Grisaru-Soen G; Lerner-Geva L; Keller N; Berger H; Passwell JH; Barzilai A
Pediatr Infect Dis J; 2000 Oct; 19(10):959-63. PubMed ID: 11055596
[TBL] [Abstract][Full Text] [Related]
31. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.
Lerner SA; Quinn JP
Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267
[TBL] [Abstract][Full Text] [Related]
32. Improved prognosis of Pseudomonas aeruginosa bacteremia in 127 consecutive neutropenic patients with hematologic malignancies.
Todeschini G; Franchini M; Tecchio C; Meneghini V; Pizzolo G; Veneri D; Murari C; Ricetti MM; Perona G
Int J Infect Dis; 1998-1999 Winter; 3(2):99-104. PubMed ID: 10225988
[TBL] [Abstract][Full Text] [Related]
33. Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections.
Elting LS; Bodey GP
Medicine (Baltimore); 1990 Sep; 69(5):296-306. PubMed ID: 2402219
[TBL] [Abstract][Full Text] [Related]
34. [Septicemia caused by Pseudomonas aeruginosa serotype O 16 in a hemato-oncology department. Review of 17 cases].
Campillo B; Richet H; Rio B; Marie JP; Arrago JP; Lagrange P; Zittoun R
Ann Med Interne (Paris); 1985; 136(8):629-33. PubMed ID: 3938628
[TBL] [Abstract][Full Text] [Related]
35. Pseudomonas aeruginosa bloodstream infections in children: a 9-year retrospective study.
Pilmis B; Alby-Laurent F; Fasola ML; Seegers V; Guery R; Guet-Revillet H; Postaire M; Toubiana J; Bille E; Lortholary O; Zahar JR
Eur J Pediatr; 2020 Aug; 179(8):1247-1254. PubMed ID: 32080759
[TBL] [Abstract][Full Text] [Related]
36. [Pseudomonas aeruginosa bacteremia associated with hematologic disorders [I]. Predisposing factors and clinical manifestations].
Funada H; Machi T; Matsuda T
Kansenshogaku Zasshi; 1989 Aug; 63(8):867-73. PubMed ID: 2507686
[TBL] [Abstract][Full Text] [Related]
37. Determinants of empirical antipseudomonal antibiotic prescription for adults with pneumonia in the emergency department.
Angrill N; Gallego M; Font J; Vallés J; Morón A; Monsó E; Rello J
BMC Pulm Med; 2020 Apr; 20(1):83. PubMed ID: 32245452
[TBL] [Abstract][Full Text] [Related]
38. Pseudomonas aeruginosa infection in cancer patients.
Rolston KV; Bodey GP
Cancer Invest; 1992; 10(1):43-59. PubMed ID: 1735012
[TBL] [Abstract][Full Text] [Related]
39. Emergence of highly antibiotic-resistant Pseudomonas aeruginosa in relation to duration of empirical antipseudomonal antibiotic treatment.
Philippe E; Weiss M; Shultz JM; Yeomans F; Ehrenkranz NJ
Clin Perform Qual Health Care; 1999; 7(2):83-7. PubMed ID: 10747571
[TBL] [Abstract][Full Text] [Related]
40. Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis.
Zelenitsky SA; Harding GK; Sun S; Ubhi K; Ariano RE
J Antimicrob Chemother; 2003 Oct; 52(4):668-74. PubMed ID: 12951354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
